TY - JOUR
T1 - Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease
AU - Chen, Chaobo
AU - Wu, Hanghang
AU - Ye, Hui
AU - Tortajada, Agustín
AU - Rodríguez-Perales, Sandra
AU - Torres-Ruiz, Raúl
AU - Vidal, August
AU - Peligros, Maria Isabel
AU - Reissing, Johanna
AU - Bruns, Tony
AU - Mohamed, Mohamed Ramadan
AU - Zheng, Kang
AU - Lujambio, Amaia
AU - Iraburu, Maria J.
AU - Colyn, Leticia
AU - Latasa, Maria Ujue
AU - Arechederra, María
AU - Fernández-Barrena, Maite G.
AU - Berasain, Carmen
AU - Vaquero, Javier
AU - Bañares, Rafael
AU - Nelson, Leonard J.
AU - Trautwein, Christian
AU - Davis, Roger J.
AU - Martinez-Naves, Eduardo
AU - Nevzorova, Yulia A.
AU - Villanueva, Alberto
AU - Avila, Matias A.
AU - Cubero, Francisco Javier
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Fibropolycystic liver disease is characterized by hyperproliferation of the biliary epithelium and the formation of multiple dilated cysts, a process associated with unfolded protein response (UPR). In the present study, we aimed to understand the mechanisms of cyst formation and UPR activation in hepatocytic c-Jun N-terminal kinase 1/2 (Jnk1/2) knockout mice. Floxed JNK1/2 (Jnkf/f) and Jnk∆hepa animals were sacrificed at different time points during progression of liver disease. Histological examination of specimens evidenced the presence of collagen fiber deposition, increased α-smooth muscle actin (αSMA), infiltration of CD45, CD11b and F4/80 cells and proinflammatory cytokines (Tnf, Tgfβ1) and liver injury (e.g., ALT, apoptosis and Ki67-positive cells) in Jnk∆hepa compared with Jnkf/f livers from 32 weeks of age. This was associated with activation of effectors of the UPR, including BiP/GRP78, CHOP and spliced XBP1. Tunicamycin (TM) challenge strongly induced ER stress and fibrosis in Jnk∆hepa animals compared with Jnkf/f littermates. Finally, thioacetamide (TAA) administration to Jnk∆hepa mice induced UPR activation, peribiliary fibrosis, liver injury and markers of biliary proliferation and cholangiocarcinoma (CCA). Orthoallografts of DEN/CCl4-treated Jnk∆hepa liver tissue triggered malignant CCA. Altogether, these results suggest that activation of the UPR in conjunction with fibrogenesis might trigger hepatic cystogenesis and early stages of CCA.
AB - Fibropolycystic liver disease is characterized by hyperproliferation of the biliary epithelium and the formation of multiple dilated cysts, a process associated with unfolded protein response (UPR). In the present study, we aimed to understand the mechanisms of cyst formation and UPR activation in hepatocytic c-Jun N-terminal kinase 1/2 (Jnk1/2) knockout mice. Floxed JNK1/2 (Jnkf/f) and Jnk∆hepa animals were sacrificed at different time points during progression of liver disease. Histological examination of specimens evidenced the presence of collagen fiber deposition, increased α-smooth muscle actin (αSMA), infiltration of CD45, CD11b and F4/80 cells and proinflammatory cytokines (Tnf, Tgfβ1) and liver injury (e.g., ALT, apoptosis and Ki67-positive cells) in Jnk∆hepa compared with Jnkf/f livers from 32 weeks of age. This was associated with activation of effectors of the UPR, including BiP/GRP78, CHOP and spliced XBP1. Tunicamycin (TM) challenge strongly induced ER stress and fibrosis in Jnk∆hepa animals compared with Jnkf/f littermates. Finally, thioacetamide (TAA) administration to Jnk∆hepa mice induced UPR activation, peribiliary fibrosis, liver injury and markers of biliary proliferation and cholangiocarcinoma (CCA). Orthoallografts of DEN/CCl4-treated Jnk∆hepa liver tissue triggered malignant CCA. Altogether, these results suggest that activation of the UPR in conjunction with fibrogenesis might trigger hepatic cystogenesis and early stages of CCA.
KW - C-Jun N-terminal kinases (JNK)
KW - CM272
KW - Cholangiocarcinoma (CCA)
KW - Endoplasmic reticulum (ER) stress
KW - Fibropolycystic liver disease
KW - Thioacetamide (TAA)
UR - http://www.scopus.com/inward/record.url?scp=85122333959&partnerID=8YFLogxK
U2 - 10.3390/cancers14010078
DO - 10.3390/cancers14010078
M3 - Article
AN - SCOPUS:85122333959
SN - 2072-6694
VL - 14
JO - Cancers
JF - Cancers
IS - 1
M1 - 78
ER -